// App-Quantinova.ai

415 : A new, highly sensitive ALK antibody improves the screening of rearranged-ALK by IHC

Researchers

Presenter

  • Hsiangmin Lu

Principal Investigators

  • Rachel Gonzalez

  • Yi Shen

  • Mu-lan Jin

  • Yipan Wu

  • Yungang Zhang

  • Kehu Yuan

  • Boyang Chu

  • Lili Qi

  • Huibo Liu

  • Chenlin Wang

  • Guangli Wang

  • Youmin Shu

  • Julie McDowell

  • Donghui Ma

  • Wei-wu He

  • Jian Chen

  • Ray Lin

Medical Centers

  • Origene Technologies, Rockville, MD

  • Department of Pathology, Beijing Chaoyang Hospital,Capital Medical University, China

  • Institute of Functional Nano and Soft Materials (FUNSOM),Soochow University, Suzhou, MD.

Locations

  • United States

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Hepatocyte growth factor receptor

Drug/Treatment

  • Crizotinib

  • L-Tyrosine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A